FDA Panel Rejects Gout Drug on Safety Concerns
Safety concerns led an FDA advisory panel to oppose approval of a new drug for gout, despite widespread enthusiasm for the medication’s effectiveness against the painful disorder.
![]()
Go here to read the rest:
FDA Panel Rejects Gout Drug on Safety Concerns

Recent Comments